Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

Open Label Extension Study of [S,S]-Reboxetine in Patients With Fibromyalgia

ClinicalTrials.gov ID: NCT00754221

Public ClinicalTrials.gov record NCT00754221. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 16, 2026, 3:13 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-center, Long-term, Open-label Extension Study of [S,S]-Reboxetine (PNU-165442G) Administered Once Daily in Patients With Fibromyalgia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a study to investigate the long-term safety and effectiveness \[S,S\]-Reboxetine in relieving the symptoms of Fibromyalgia in patients.

Study identification

NCT ID
NCT00754221
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
390 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2008
Primary completion
Apr 30, 2009
Completion
Apr 30, 2009
Last update posted
Dec 16, 2019

2008 – 2009

United States locations

U.S. sites
101
U.S. states
32
U.S. cities
90
Facility City State ZIP Site status
Pfizer Investigational Site Birmingham Alabama 35242
Pfizer Investigational Site Phoenix Arizona 85023
Pfizer Investigational Site Tucson Arizona 85741
Pfizer Investigational Site Elk Grove California 95758
Pfizer Investigational Site Fullerton California 92835
Pfizer Investigational Site Lafayette California 94549
Pfizer Investigational Site Northridge California 91325
Pfizer Investigational Site Oceanside California 92056
Pfizer Investigational Site Roseville California 95661
Pfizer Investigational Site Sacramento California 95816
Pfizer Investigational Site San Jose California 95124
Pfizer Investigational Site Santa Ana California 92705
Pfizer Investigational Site New London Connecticut 06320
Pfizer Investigational Site Brooksville Florida 34613
Pfizer Investigational Site Jacksonville Florida 32216
Pfizer Investigational Site Jacksonville Florida 32223
Pfizer Investigational Site Ocala Florida 34471
Pfizer Investigational Site Ocala Florida 34474
Pfizer Investigational Site St. Petersburg Florida 33709
Pfizer Investigational Site Sunrise Florida 33351
Pfizer Investigational Site Tampa Florida 33606
Pfizer Investigational Site Tampa Florida 33614
Pfizer Investigational Site West Palm Beach Florida 33407
Pfizer Investigational Site Winter Haven Florida 33880
Pfizer Investigational Site Atlanta Georgia 30328
Pfizer Investigational Site Gurnee Illinois 60031
Pfizer Investigational Site Moline Illinois 61265
Pfizer Investigational Site Oak Brook Illinois 60523
Pfizer Investigational Site Indianapolis Indiana 46250
Pfizer Investigational Site Indianapolis Indiana 46260
Pfizer Investigational Site Overland Park Kansas 66212
Pfizer Investigational Site Overland Park Kansas 66215
Pfizer Investigational Site Pratt Kansas 67124
Pfizer Investigational Site Louisville Kentucky 40213
Pfizer Investigational Site Madisonville Kentucky 42431
Pfizer Investigational Site Mount Sterling Kentucky 40353
Pfizer Investigational Site Baton Rouge Louisiana 70809
Pfizer Investigational Site Wheaton Maryland 20902
Pfizer Investigational Site Boston Massachusetts 02135
Pfizer Investigational Site Brockton Massachusetts 02301
Pfizer Investigational Site Fall River Massachusetts 02720
Pfizer Investigational Site North Dartmouth Massachusetts 02747
Pfizer Investigational Site Watertown Massachusetts 02472
Pfizer Investigational Site Wellesley Hills Massachusetts 02481-2106
Pfizer Investigational Site Worcester Massachusetts 01610
Pfizer Investigational Site Ann Arbor Michigan 48103
Pfizer Investigational Site Chaska Minnesota 55318
Pfizer Investigational Site Edina Minnesota 55435
Pfizer Investigational Site Olive Branch Mississippi 38654
Pfizer Investigational Site Columbia Missouri 65203
Pfizer Investigational Site Columbia Missouri 65212
Pfizer Investigational Site Jefferson City Missouri 65109
Pfizer Investigational Site St Louis Missouri 63141
Pfizer Investigational Site Omaha Nebraska 68134
Pfizer Investigational Site Las Vegas Nevada 89119
Pfizer Investigational Site Albuquerque New Mexico 87109
Pfizer Investigational Site Albany New York 12205
Pfizer Investigational Site Brooklyn New York 11235
Pfizer Investigational Site Rochester New York 14610
Pfizer Investigational Site Rochester New York 14618
Pfizer Investigational Site The Bronx New York 10454
Pfizer Investigational Site Charlotte North Carolina 28209-3734
Pfizer Investigational Site Salisbury North Carolina 28144
Pfizer Investigational Site Cincinnati Ohio 45219
Pfizer Investigational Site Cincinnati Ohio 45227
Pfizer Investigational Site Columbus Ohio 43213
Pfizer Investigational Site Dayton Ohio 45408
Pfizer Investigational Site Toledo Ohio 43623
Pfizer Investigational Site Bend Oregon 97701
Pfizer Investigational Site Eugene Oregon 97401
Pfizer Investigational Site Medford Oregon 97504
Pfizer Investigational Site Portland Oregon 97219
Pfizer Investigational Site Altoona Pennsylvania 16602
Pfizer Investigational Site Bethlehem Pennsylvania 18015
Pfizer Investigational Site Bridgeville Pennsylvania 15017
Pfizer Investigational Site Duncansville Pennsylvania 16635
Pfizer Investigational Site Pittsburgh Pennsylvania 15216
Pfizer Investigational Site Pittsburgh Pennsylvania 15241
Pfizer Investigational Site Pittsburgh Pennsylvania 15243
Pfizer Investigational Site West Reading Pennsylvania 19611-1124
Pfizer Investigational Site Cumberland Rhode Island 02864
Pfizer Investigational Site Bristol Tennessee 37620
Pfizer Investigational Site Nashville Tennessee 37203
Pfizer Investigational Site Austin Texas 78758
Pfizer Investigational Site Austin Texas 78759
Pfizer Investigational Site Beaumont Texas 77701
Pfizer Investigational Site Bryan Texas 77802
Pfizer Investigational Site Dallas Texas 75231
Pfizer Investigational Site DeSoto Texas 75115
Pfizer Investigational Site Lake Jackson Texas 77566
Pfizer Investigational Site Nassau Bay Texas 77058
Pfizer Investigational Site San Antonio Texas 78229
Pfizer Investigational Site Ogden Utah 84405
Pfizer Investigational Site Salt Lake City Utah 84107
Pfizer Investigational Site Arlington Virginia 22205-3617
Pfizer Investigational Site Charlottesville Virginia 22911
Pfizer Investigational Site Virginia Beach Virginia 23455
Pfizer Investigational Site Kirkland Washington 98033
Pfizer Investigational Site Spokane Washington 99216
Pfizer Investigational Site Milwaukee Wisconsin 53209-0966
Pfizer Investigational Site Oregon Wisconsin 53575

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 8 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00754221, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 16, 2019 · Synced Sep 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00754221 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →